Buffett's ongoing purchase of large volumes of OXY, as well as buyouts by the Bill & Melinda Gates Foundation should lead to the growth of the paper, which is still quite attractive in terms of financial performance.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.